Cigarette smoking differentially alters local adaptive immune signaling in Stage III periodontitis
Clinical Oral Investigations, cilt.30, sa.12, 2026 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 30 Sayı: 12
- Basım Tarihi: 2026
- Doi Numarası: 10.1007/s00784-026-07263-2
- Dergi Adı: Clinical Oral Investigations
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE, Academic Search Ultimate (EBSCO), Natural Science Collection (ProQuest), Biological Science Database (ProQuest), Biomedical Reference Collection: Corporate Edition (EBSCO), Health Research Premium Collection (ProQuest), Pharma Collection (ProQuest)
- Anahtar Kelimeler: Adaptive immunity, Cigarette smoking, Gingival crevicular fluid, Interleukin-16, Periodontitis, Serum
- İstanbul Kent Üniversitesi Adresli: Evet
Özet
Objectives: Cigarette smoking impairs periodontal host defense, yet its effects on local adaptive immune cytokine signaling remain poorly characterized. This cross-sectional study quantified a seven-cytokine panel in gingival crevicular fluid (GCF) and matched serum from patients with Stage III periodontitis and healthy controls, stratified by smoking status. Materials and methods: Fifty adults were enrolled across four groups: periodontally healthy non-smokers (Group 1, n = 10), periodontally healthy smokers (Group 2, n = 10), Stage III, Grade C periodontitis non-smokers (Group 3, n = 10), and periodontitis smokers (Group 4, n = 20). Seven cytokines (IL-1β, IL-2, IL-6, IL-8, IL-12p40, IL-16, TNF-α) were quantified by Luminex™ multiplex immunoassay in GCF and serum. Spearman correlations were computed per smoking stratum with Benjamini-Hochberg FDR correction; effect sizes and 95% CIs were calculated. Results: GCF IL-16 and IL-8 were significantly lower in smoking than non-smoking periodontitis patients (p < 0.001 and p < 0.01, respectively). GCF IL-6, IL-12p40, and TNF-α differed significantly across groups (all p < 0.05). In non-smokers, GCF IL-16 showed positive correlations with clinical inflammatory parameters; these associations were absent in smokers. Serum IL-6 differed between non-smoking and smoking periodontitis patients (p < 0.05). Serum IL-16 and IL-8 were not significantly different by smoking status. Serum IL-2 was undetectable across all groups. Conclusions: Cigarette smoking was associated with suppression of GCF IL-16 and IL-8 in Stage III periodontitis, with concurrent loss of their positive correlations with clinical inflammatory parameters, not reflected in serum. Clinical relevance: Standard serum biomarkers may not capture local immune dysregulation in tobacco-exposed periodontal patients. GCF multiplex profiling of IL-16 and IL-8 may complement clinical assessment and immune monitoring in smokers with periodontitis.